HonCode

Go Back   HER2 Support Group Forums > Search Forums
Reload this Page Search Results
Register Gallery FAQ Members List Calendar Today's Posts

Page 1 of 20 1 2311 Last »
Showing results 1 to 25 of 500
Search took 0.40 seconds. Search: Posts Made By: Lani
Forum: her2group 06-27-2024, 09:30 PM
Replies: 0
Views: 2,385
Posted By Lani
fabulous trial results for TDM-1 foe Stage 1 her2+bc--97% effective

NEWS RELEASE 27-JUN-2024
Antibody-drug conjugate highly effective in preventing recurrence in patients with early stage HER2+ breast cancer, trial finds
Peer-Reviewed Publication
DANA-FARBER...
Forum: her2group 06-25-2024, 10:26 AM
Replies: 0
Views: 1,601
Posted By Lani
new Hsp90 inhibitor promising vs Herceptin-resistant her2+ bc

https://www.eurekalert.org/news-releases/1049364



NEWS RELEASE 25-JUN-2024
Korea University identifies novel inhibitor HVH-2930 showing promise in overcoming trastuzumab resistance in...
Forum: her2group 10-13-2021, 04:29 PM
Replies: 0
Views: 5,826
Posted By Lani
Thumbs up focused ultrasound delivers antibody therapy vs bc brain mets

ADVANCED SEARCH
EurekAlert! Science News A service of the American Association for the Advancement of Science

NEWS RELEASE 13-OCT-2021
World-first clinical trial demonstrates focused...
Forum: her2group 09-18-2021, 12:31 AM
Replies: 1
Views: 6,592
Posted By Lani
HER2-targeting antibody-drug improves progression-free survival

https://www.eurekalert.org/images/logo-2x.png (https://www.eurekalert.org/) https://www.eurekalert.org/images/brand.png (https://www.eurekalert.org/)






NEWS RELEASES...
Forum: her2group 11-14-2020, 09:05 PM
Replies: 0
Views: 5,946
Posted By Lani
Final Efficacy Results of Neratinib in HER2+ER+ early bc

full text links

https://cdn-ncbi-nlm-nih-gov.laneproxy.stanford.edu/corehtml/query/egifs/tools/DB__1__13__3140.gif (http://sfx.stanford.edu/local?sid=Entrez:PubMed&id=pmid:33183970)

actions...
Forum: her2group 09-23-2020, 09:14 AM
Replies: 0
Views: 5,295
Posted By Lani
FDA APPROVES 1st PAN-TUMOUR LIQUID BIOPSY TEST FOR PATIENTS WITH ADVAnced CANCER

FDA APPROVES FIRST COMPREHENSIVE PAN-TUMOUR LIQUID BIOPSY TEST FOR PATIENTS WITH ADVANCED CANCER

A qualitative next generation sequencing based in vitro diagnostic test analyzes more than 300...
Forum: her2group 07-18-2020, 09:26 PM
Replies: 1
Views: 6,111
Posted By Lani
Thumbs up DE-ESCALATING TREATMENT FOR HER2+ early breast cancer

Trans Am Clin Climatol Assocv.131; 2020PMC7358497

Trans Am Clin Climatol Assoc. 2020; 131: 119–126.
PMCID: PMC7358497
PMID: 32675852
DE-ESCALATING TREATMENT FOR HER2-POSITIVE EARLY BREAST...
Forum: her2group 07-18-2020, 08:55 PM
Replies: 0
Views: 3,476
Posted By Lani
Thumbs up Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2+ Metastatic

Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Tria


J Clin Oncol
. 2020 Jul 17;JCO2000147. doi: 10.1200/JCO.20.00147. Online ahead of print.
Neratinib Plus...
Forum: her2group 07-05-2020, 12:04 PM
Replies: 2
Views: 4,330
Posted By Lani
GREAT NEWS: FDA approves at home submit dual anti-her2/3 therapy

can home hylecta be far behind?


FDA Approves In-home Breast Cancer Treatment

Advantageous for Infusion Centers?

Nick Mulcahy
June 29, 2020
Forum: her2group 06-18-2020, 12:47 PM
Replies: 4
Views: 8,924
Posted By Lani
Thumbs up Tucatinib Is Active Against Brain Metastases in HER2+ Breast Cancer

Research Watch
Tucatinib Is Active Against Brain Metastases in HER2+ Breast Cancer






DOI: 10.1158/2159-8290.CD-RW2020-087
Forum: her2group 05-31-2020, 06:38 PM
Replies: 1
Views: 3,689
Posted By Lani
Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2+ Brea

Breast Cancer With Brain Metastases in the HER2CLIMB Trial


J Clin Oncol
. 2020 May 29;JCO2000775. doi: 10.1200/JCO.20.00775. Online ahead of print.
Intracranial Efficacy and Survival With...
Forum: her2group 05-01-2020, 10:24 PM
Replies: 1
Views: 3,692
Posted By Lani
Thumbs up Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus

standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive stage 4 breast cancer



Lancet Oncol. 2020 Apr 27. pii: S1470-2045(20)30112-1. doi:...
Forum: her2group 04-30-2020, 08:00 AM
Replies: 0
Views: 3,131
Posted By Lani
for those with lepto-meningeal mets

J Neurooncol. 2020 Apr 29. doi: 10.1007/s11060-020-03510-y. [Epub ahead of print]
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP...
Forum: her2group 04-29-2020, 06:59 PM
Replies: 1
Views: 3,373
Posted By Lani
Re: FDA approves tucatinib for Stage 4 her2+ breast cancer

Cancer
CancerScope Free Access
Addition of tucatinib to trastuzumab and chemotherapy improves survival for patients with metastatic, HER2‐positive breast cancer
Carrie Printz
First published: 28...
Forum: her2group 04-28-2020, 07:59 AM
Replies: 1
Views: 3,373
Posted By Lani
FDA approves tucatinib for Stage 4 her2+ breast cancer

U.S. Food and Drug Administration FDA approves tucatinib for patients with HER2-positive metastatic breast cancer
FDA approves tucatinib for patients with HER2-positive metastatic breast cancer...
Forum: her2group 03-21-2020, 12:36 PM
Replies: 1
Views: 3,420
Posted By Lani
any hope of getting insurance companies to cover hylecta in view of covid19 pandemic?

utilizes. less hospital/clinic time, resources AND PERHAPS COULD BE GIVEN BY HOME HEALTH NURSES OR PCP office


thoughts?

Lani
Forum: her2group 01-25-2020, 07:19 PM
Replies: 0
Views: 3,437
Posted By Lani
Thumbs up mtor inhibitor reverses resistance to neratinib

NEWS RELEASE 23-JAN-2020
Researchers uncover two-drug combo that halts the growth of cancer cells

Discovery could counter resistance to promising new breast cancer therapy
UT SOUTHWESTERN...
Forum: her2group 12-20-2019, 03:55 PM
Replies: 0
Views: 2,944
Posted By Lani
Lightbulb DS8201 accelerated approval by FDA

HEALTH NEWSDECEMBER 20, 2019 / 10:47 PM / UPDATED AN HOUR AGO
AstraZeneca, Daiichi's breast cancer drug gets accelerated approval from FDA
2 MIN READ
FREUTERS/Brendan McDermid
(Reuters) - The...
Forum: her2group 12-11-2019, 06:48 PM
Replies: 0
Views: 2,731
Posted By Lani
sabcs: Updated APHINITY Supports Benefit of Dual HER2 Blockade

www.medscape.com

Updated APHINITY Supports Benefit of Dual HER2 Blockade
Pam Harrison

December 11, 2019

SAN ANTONIO, Texas — An updated analysis of the APHINITY trial strengthens earlier...
Forum: her2group 12-11-2019, 03:22 PM
Replies: 0
Views: 3,011
Posted By Lani
Thumbs up remarkable new drug for her2+mbc effective after many previous lines of treatment

HEALTH NEWSDECEMBER 11, 2019 / 2:12 PM / UPDATED 9 HOURS AGO
AstraZeneca-Daiichi drug halts cancer for months in first readout

(Reuters) - An experimental cancer drug developed by AstraZeneca and...
Forum: her2group 12-11-2019, 09:51 AM
Replies: 1
Views: 3,097
Posted By Lani
Thumbs up SABCS: Tucatinib 'game changing' vs HER2+ MBC, especially w brain mets

News Release 11-Dec-2019 Tucatinib 'game changing' against HER2+ breast cancer, especially with brain metastases

...
Forum: her2group 12-07-2019, 01:39 PM
Replies: 0
Views: 3,099
Posted By Lani
Outcomes in HR+/HER2+ Metastatic Breast Cancer Pts: A Natnl Cancer Database Analysis

Format: Abstract

Send to
Sci Rep. 2019 Dec 2;9(1):18126. doi: 10.1038/s41598-019-54402-9.
Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National...
Forum: her2group 12-07-2019, 12:54 PM
Replies: 0
Views: 2,647
Posted By Lani
NSABP FB-7 paclitaxel + herceptin +/_neratinib

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2 + breast cancer | Breast Cancer...
Forum: her2group 09-18-2019, 09:37 AM
Replies: 0
Views: 3,271
Posted By Lani
guide to treatment deescalation: her2 heterogeneity predicts response2 preop tdm1 &

pertuzumab combo


ASCO Reading Room 09.17.2019
HER2 Heterogeneity and Response to Neoadjuvant Therapy
Study confirms lower rates of HER2 expression, pCR in HER2+ breast cancer treated with...
Forum: her2group 09-12-2019, 04:59 PM
Replies: 72
Views: 60,404
Posted By Lani
Re: Whack-a-mole next...

Vantage Logo May 08, 2019
Astra and Daiichi lay out their plan for a better Herceptin


Jacob Plieth
The companies’ DS-8201 succeeds in breast cancer patients who had failed Kadcyla, and...
Showing results 1 to 25 of 500
Page 1 of 20 1 2311 Last »

 
Forum Jump

All times are GMT -7. The time now is 05:20 AM.
Contact Us - HER2 Support Group - Archive - Privacy Statement - Top

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter